Skip to Main Content
An official website of the United States government
Upcoming Login Change: On or about August 24, CDAS will begin using the NIH Researcher Auth Service (RAS) to manage our existing login options. When logging into CDAS, you will be taken to RAS, where you can select your preferred login provider to access CDAS.

Efficacy of Prostate-Specific Antigen Screening: Use of Regression Discontinuity in the PLCO Cancer Screening Trial.

Authors

Shoag J, Halpern J, Eisner B, Lee R, Mittal S, Barbieri CE, Shoag D

Affiliations

  • Department of Urology, New York Presbyterian Hospital, Weill Cornell Medical College, New York.
  • Department of Urology, Massachusetts General Hospital, Boston.
  • Department of Public Policy, Harvard Kennedy School, Cambridge, Massachusetts.

Abstract

N/A
Back to Publication Search

Publication Details

PubMed ID
26291583

Publication
JAMA Oncol. 2015 Oct; Volume 1 (Issue 7): Pages 984-6

Related CDAS Studies Related CDAS Studies